Kidney Cancer

Delayed diagnosis too common.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.

Genetic nondiscrimination bill on its way to becoming law.

Gamers take virtual shot at cancer.

Statistics on the long-term heart effects of therapy include risk factors that increase the likelihood of heart damage in a childhood cancer survivor.

Cognitive dysfunction remains a problem for young patients.

A documentary film about kids with cancer and their families.

Tips for parents--there are several things parents can do to make their other children feel special and involved in their sibling's cancer battle.

In addition to treatment-related risks, some survivors discover they have a genetic syndrome that may lead to a second cancer.

Updates from the 2006 annual meeting of the American Society of Clinical Oncology.

Revlimid is approved for certain types of myelodysplastic syndrome, and Sutent was approved for both advanced kidney cancer and gastrointestinal stromal tumor.

Advanced treatments take form for a notoriously hard-to-beat cancer.